GSK

We are a focused biopharma company with strong momentum and big ambitions, to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive.

We get ahead of disease by preventing and treating it with innovation in vaccines and specialty medicines. At the heart of this is our R&D focus on the science of the immune system and advanced technologies, and our world-leading capabilities in vaccine and medicines development. We focus on four therapeutic areas: infectious diseases, HIV, respiratory/immunology, and oncology.

In Australia, we employ approximately 600 Australians in many areas of expertise, from graduates to senior managers. We have committed to accelerate our progress on inclusion and diversity, and seek to make a meaningful and lasting contribution to reconciliation.

We have ambitious environmental sustainability goals in both climate and nature: aiming to have a net zero impact on climate by 2030 and a net positive impact on nature by 2030.

For more information visit au.gsk.com.

Upcoming GSK Sponsored Events and Education
Immunotherapy a History and Future.png
2 CPD

Immunotherapy: a History and Future

 

Recap on GSK Education